CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE: Release of a capital market information
CompuGroup Medical SE / Share Buyback 27.08.2018 / 14:43 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 6th Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, August 27, 2018 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 6th Interim Announcement In the period from August 20, 2018, up to and including August 24, 2018, CompuGroup Medical SE has bought back a total of 27,254 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018. The overall volume of the shares bought back daily in the period from August 20, 2018, up to and including August 24, 2018, and the daily volume- weighted average stock market prices of the shares are as follows:Date Overall volume of Volume-weighted average stock shares bought back market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) August 20, 2018 6,515 48.9134 August 21, 2018 5,229 48.9122 August 22, 2018 6,010 49,4051 August 23, 2018 6,000 50.3747 August 24, 2018 3,500 50.2651 In total: 27,254 49.5169The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including August 24, 2018, within the framework of the share buyback program thus amounts to 223,077 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, August 27, 2018 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 --------------------------------------------------------------------------- 27.08.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Internet: www.cgm.com End of News DGAP News Service
Aktuelle News
Aktuelle Berichte
Anstehende Events
Events Funktionen
Weitere Funktionen
Webcasts
Keine Webcasts gefunden